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ABSTRACT
Objectives: The SF-6D is a preference-based measure of health derived
from the SF-36 that can be used for cost-effectiveness analysis using
cost-per-quality adjusted life-year analysis. This study seeks to estimate a
system weight for the SF-6D for Portugal and to compare the results with
the UK system weights.
Methods: A sample of 55 health states deﬁned by the SF-6D has been
valued by a representative random sample of the Portuguese population,
stratiﬁed by sex and age (n = 140), using the Standard Gamble (SG).
Several models are estimated at both the individual and aggregate levels
for predicting health-state valuations. Models with main effects, with
interaction effects and with the constant forced to unity are presented.
Random effects (RE) models are estimated using generalized least squares
(GLS) regressions. Generalized estimation equations (GEE) are used to
estimate RE models with the constant forced to unity. Estimations at the
individual level were performed using 630 health-state valuations. Alter-
native functional forms are considered to account for the skewed distri-
bution of health-state valuations.
Results: The models are analyzed in terms of their coefﬁcients, overall ﬁt,
and the ability for predicting the SG-values. The RE models estimated
using GLS and through GEE produce signiﬁcant coefﬁcients, which are
robust across model speciﬁcation. However, there are concerns regarding
some inconsistent estimates, and so parsimonious consistent models were
estimated. There is evidence of under prediction in some states assigned to
poor health. The results are consistent with the UK results.
Conclusion: The models estimated provide preference-based quality of
life weights for the Portuguese population when health status data have
been collected using the SF-36. Although the sample was randomly
drowned ﬁndings should be treated with caution, given the small
sample size, even knowing that they have been estimated at the indi-
vidual level.
Keywords: health-related quality of life, preference-based measure, SF-6D,
system weight.
Introduction
Economic evaluation involving cost-effectiveness analysis is
increasingly being used to inform resource allocation in health
care. Cost effectiveness analysis using cost-per-quality adjusted
life-year (QALY) analysis enables comparisons across a wide
range of diseases and treatments using a common measurement.
The “quality” part of the QALY is estimated using a preference-
based measure of health. This preference-based measure pro-
duces a single preference-based index that can also be used to
enable comparisons between socioeconomic groups and the
investigation of the magnitude of health status utility differences.
The SF-36 is one of the most commonly used measures of
health-related quality of life (HRQoL), yet cannot be used in
economic evaluation in its existing form because it cannot gen-
erate a single preference-based index. The SF-6D is a recent
preference-based, indirect utility assessment instrument created
by Brazier et al. [1] and is derived from the SF-36. The SF-6D
enables a utility score to be generated from the SF-36 for use in
cost-per-QALY analysis. Brazier et al. [1] produced a set of pref-
erence weights for the UK general population but non-UK popu-
lations may have different preferences to non-UK populations.
This study seeks to estimate a system weight for the SF-6D for
Portugal and to compare the results with the UK system weights.
In this article, we present the valuation survey undertaken with
the SF-6D and the modeling results.
The SF-36
The SF-36 is a generic measure of (HRQoL) HRQoL which
assesses health using 36 items across eight dimensions. Each
dimension is given a score on a 0–100 scale but these scores
cannot be used to generate QALYs because they are not based
on individual preferences and are not comparable across
dimensions.
The SF-6D
The SF-6D was derived from 11 items of the SF-36 and converted
into a six-dimensional health-state classiﬁcation system, with
four to six levels each dimension, allowing for 18,000 unique
health states [1]. Dimensions of the SF-6D include: physical
functioning, role limitations, social functioning, pain, mental
health, and vitality. The SF-6D has a set of preference weights
obtained from standard gamble (SG) valuations of a sample of
249 SF-6D health states using a representative sample of the UK
population [1]. The SF-6D can be regarded as a continuous
outcome measure anchored on a full health-death 1–0 scale
where the preference weights range from 0.30 to 1.00 [1]. Since
the recent introduction of this preference-based measure, several
articles have been published using the SF-6D, e.g. [2–10], and it
is anticipated that the application of this measure will continue to
grow.
Methods
Study Design
This study has two major components: to estimate a system
weight for the SF-6D for Portugal, and to compare the results to
the UK system weights. For the ﬁrst component, we replicate the
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methods followed by Brazier and colleagues [1]. First, we under-
took a preference based valuation survey and, second, we
modeled the data to estimate a Portuguese system weight for the
SF-6D (PT SF-6D). For the second component, we compared the
ﬁnal Portuguese system weight (PT SF-6D) with the UK system
weight (UK SF-6D).
An optimal stratiﬁed sampling design was used to achieve a
representative sample of the general adult Portuguese population
that reﬂects the variability of the Portuguese population in terms
of age and sex. The estimated sample size was 140 individuals,
with a conﬁdence degree of 95% and a relative precision of
4.60%. Individuals were randomly selected from a survey frame
of the Portuguese population over 15 years old including name,
address, sex, age and residence. The interviews were conducted
in the respondents own homes, between April and October 2006.
Each respondent ranked a set of health states deﬁned by the
Portuguese SF-6D and valued these using SG. The Portuguese
version of the SF-6D was obtained from the Portuguese version
of SF-36 v2 by extracting the 11 items referred in Brazier et al.
[1]. To familiarize respondents with the idea of describing health
in terms of the SF-6D and as a warm-up exercise, each respon-
dent was ﬁrst asked to describe their health using the Portuguese
versions of the SF-36 v2, the EQ-5D descriptive system, the
EQ-5D Visual Analogue Scale and the SF-6D (results not pre-
sented). The interviews began with an exercise to rank six health
states deﬁned by the SF-6D, plus the best (111111) and the worst
(645655) health states deﬁned by the SF-6D and immediate
death. Following other researchers [11], we assumed that the
ranking exercise is equivalent to the respondent making a series
of individual selections from smaller and smaller sets of states.
Respondents were then asked to value the six health states
using SG. The SG valuation was based on a variant of the SG
using props developed by a team at McMaster [12]. A chance
board was used to present the probabilities of both alternatives,
both numerically and in a pie chart. Due to its ease of use, the
ping-pong (i.e., alternating back-and-forth between high and low
values) strategy was employed in the interviews. All interviewers
used the interview schedules, response booklets and chance
boards suggested by the McMaster team [12]. The research team
recruited 10 students to perform the interviews and trained them.
No incentive was given to the respondents before or after the
interview took place. Following the method used by Brazier et al.
[1], after the six SG questions, the respondents were asked a
seventh SG question, the form of which depended upon the form
they had ranked the “pits” state: better than or worse than
immediate death. If they had ranked the “pits” health state as
better than immediate death, they were asked to consider a
choice between the uncertain prospect of full health (111111) or
immediate death and the certain prospect of being in the “pits”
state (645655). On the contrary, if they had ranked the “pits”
health state as worse than immediate death, they were asked to
consider a choice between the uncertain prospect of full health or
being in the “pits” state and the certain prospect of immediate
death. The response to this SG question was then used to “chain”
the health-state values to place them on the full health-death
scale (1–0) [1]. The adjustment of the six intermediate SF-6D
health-state valuations was made in the following way [1]:
SGadj = SG + (1 - SG)P, where SGadj is the adjusted SF-6D
health-state valuation; SG is the SF-6D health-state valuation;
and P is the value of the “pits” state. Respondents were ﬁnally
asked some socio-demographic questions.
Selection of the Health States
The SF-6D generates 18,000 different health states. Because it is
virtually impossible to value all states, a selection of a number of
health states was needed. To compare the results of this research
with those of Brazier and colleagues [1], we used the same set of
health states as a starting point. Because the minimum sample of
health states identiﬁed using an orthogonal design is 49 health
states, we used the same 49 health states determined by Brazier
et al. [1] by applying the orthoplan procedure of the Statistical
Package for the Social Sciences (SPSS). Five additional health
states were randomly generated to maximize the number of
health states valued. Hence, the respondents valued a total of 54
health states, plus the worst health state deﬁned by the SF-6D.
These states were classiﬁed as mild, moderate, or severe and a
stratiﬁed sampling method was used to ensure that each respon-
dent was asked to value a set of states from all levels. The severity
of the states was assessed by summing the dimension levels,
following a recently published approach [13]. The states were
then ranked using the score and divided into quartiles to identify
the three severity groups. Two health states were then randomly
selected without replacement from each group to create nine sets
of health states containing six states each. Each health state and
set was valued 10 times on average (minimum 9, maximum of
11), adding up to 630 valuations. Table 1 presents the states
chosen for the valuation task.
Modeling Health-State Values
Regression analysis is used to estimate the relationship between
the SF-6D and the SG values. These models can then be used to
predict health-state values for all states deﬁned by the classiﬁca-
tion system. Models were estimated at both the individual and
aggregate levels because there may be a respondent effect caused
by variations between and within respondents [1,14]. First, an
ordinary least squares (OLS) regression was used, which relies on
the assumption that each individual health-state value is an inde-
pendent observation. Models with main effects, with interaction
effects and with the constant forced to unity were estimated.
Breush-Pagan tests revealed heteroscedasticity problems in all
Table 1 SF-6D Health states valued in the survey
Number of health states: 54 + worst
211111 144341
121212 224612
232111 534113
113411 633122
321122 235224
111621 334251
122233 414522
133132 432621
511114 431443
611221 443215
213323 622513
312332 625141
332411 315515
341123 115653
124125 523551
135312 642612
212145 323644
412152 545422
421314 614434
522321 531635
122425 631355
131542 115323
221452 211424
241531 112554
425131 611434
512242 645621
132524 645655
142154
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models. To deal with this, all models were estimated using
White’s heteroscedasticity consistent standard errors.
The model speciﬁcation at the individual level is:
yij ij ij ij= + ′ + ′ +α εx rb q , (1)
where i = 1,2, . . . , n represents the health states, j = 1,2, . . . , m
represents the respondents, yij is the adjusted values of the health
state i valued by respondent j, ′ = ( )xij ij ij vijx x x1 2, , . . . , is a vector
of v dummy explanatory variables referenced to the same unity,
in which xvij = xdlij for each level l of dimension d of the SF-6D.
The ′ = ( )rij ij ij uijr r r1 2, , . . . , term is a vector of u variables of inter-
action between the different levels of the attributes, also refer-
enced to the same unity. Further, b = (b1, b2, . . . , bv) and
q = (q1, q2, . . . , qu) are vectors of parameters and eij is a residual
variable.
At the aggregate level the model is:
yi i i i= + ′ + ′ +α εx rb q (2)
where yi is the adjusted aggregated value of the health state i.
Second, random effects (RE) models were estimated using
generalized least squares (GLS) regressions, allowing for more
complex modeling of the variance components observed at both
levels of the hierarchy [15]. Models with main effects and with
interaction effects are presented. The general RE model is:
y u eij ij ij j ij= + ′ + ′ + +α x rb q , (3)
where uj is the respondent-speciﬁc variation that is assumed to be
random across individual respondents and eij is an error term for
the ith health-state valuation of the jth individual, assuming that
it varies randomly across observations, with eij e∼ 0 2, σ[ ]. Addi-
tionally, Cov(uj, eij) = 0, which means that the health states are
randomly allocated to the respondents. The Hausman test was
used to test the appropriateness of random effects [16] and the
Breush-Pagan Lagrange Multiplier (B-P LM) test was employed
to compare the RE GLS and OLS models.
Third, the generalized estimating equations (GEE) approach
was used, which is a widely used statistical method in the analysis
of longitudinal data in clinical epidemiological studies. It was
proposed by Liang and Zeger [17] and Zeger and Liang [18] and
is an extension of the generalized linear model algorithm to
accommodate correlated data. The GEE approach was used to
estimate the RE models with the constant forced to unity, by
means of an exchangeable correlation structure. The Hausman
test was used to formally test the difference between the ﬁxed
effects (FE) and the GEE parameters.
Alternative functional forms were considered to account for
the skewed distribution of health-state valuations. A logit, two
log-log transformations, and a Tobit transformation were
applied. The log-log transformation presented in this article is:
ln ln− − +( )( )⎡⎣⎢ ⎤⎦⎥1 12 1SGadj , where SGadj is the SG value adjusted to
the scale 1–0 (full health-death) as also used in the other models.
All functional forms were modeled with RE and GEE. Once
again, the Hausman test and the B-P LM test were applied to test
the appropriateness of RE.
Because there are potentially thousands of possible interac-
tion effects that could be included in the models, we followed
others researchers’ approach [1,14] and reduced the interactions
by considering a dummy variable (WORSE) for all situations
where one or more dimensions are at the worst possible level.
Also following the same approach [1,14], all models were
analyzed regarding the expected negative sign and statistical
signiﬁcance (P < 0.10) of the coefﬁcients, number of inconsisten-
cies and of its statistical signiﬁcance, overall ﬁt, and the ability
for predicting the SG values for all health states. In common with
the literature, we expect coefﬁcients to be negative and increasing
in absolute size because the dummy variables represent progres-
sively worse problems on each dimension in comparison to the
baseline for that dimension. When a coefﬁcient decreases in
absolute size, an inconsistency occurs.
Predictive performance of the models is assessed using the
following battery of measures: adjusted R2, mean absolute error
(MAE), proportion of health-state values correctly predicted
within an error lower than 0.1 (%AE < |0.10|) and than 0.05
(%AE < |0.05|). Goodness of ﬁt assessment includes Akaike’s
information criterion (AIC) and Bayes information criterion
(BIC). Because the GEE method is based on the quasi-likelihood
theory, some of the model selection statistics developed under the
maximum likelihood theory cannot be applied directly [19].
Therefore, we use an extension of AIC proposed by Pan [20] that
uses the quasi-likelihood under the independence model infor-
mation criterion (QIC) as model selection method. Ramsey’s
Reset tests (RESET) and tests to the nullity of residuals mean
[t(mean = 0)] were also applied. Normality of residuals is tested
using the asymptotic Jarque-Bera test (JB) and skewness and
kurtosis tests for normality. The overall signiﬁcance of the
models is tested using an F test or a Wald-type test (W(c2)), as
appropriate. All analyses are performed using Stata, release 9.0.
Results
Sample
Table 2 shows the main characteristics of the study sample. The
sample includes a slight majority of women (53.6%). Age ranges
Table 2 Study sample and Portuguese population
N %
Portuguese Population
over 15 years old (%)
Sample (n) 140 100.0 100.0
Female 75 53.6 52.3
Married/living together 86 61.4 63.5
High Educational Level 54 38.6 13.7
Skilled white collar workers 56 40.6 15.5
Living in urban areas 122 87.1 n.a.
Income: 1,000€–1,999€ 54 39.4 n.a.
No chronic disease 90 64.3 63.4
Mean age (standard deviation) 42.7 (16.9) 46.5 (16.8)
All values for Portuguese population are based on Portuguese Census 2001 except for the number of individuals with no chronic disease, which is based on 2005/2006 Portuguese National
Health Survey.
n.a., not available.
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from 15 to 87 years with a mean age of 43 years old (SD = 16.9).
The majority of the sample are married or living together as a
couple although 30.0% (42) are single. Almost 39% of the
sample has a high educational level while 34% (47) with a
middle educational level. Respondents are most frequently
skilled nonmanual workers (40.6%), living in urban areas
(87.1%) and reporting no chronic disease (64.3%). Although
39.4% of the sample had an income between 1000€ and 1999€,
22.6% (31) earned more than 3000€. As was said in the methods
section, this random sample is representative of the general adult
Portuguese population in terms of age and sex.
Health-State Values
Descriptive statistics for the health states are reported in Table 3.
The number of valuations per health state is also presented. The
mean health-state valuation is 0.595 (SD = 0.290) and mean
health-state values range from 0.217 (614434) to 0.831 (232111).
The range of individual values is -0.500 (645655) and 0.993
(121212; 412152; 213323; 212145).Negative values are assigned
to some severe health states, but are relatively rare (3.8%).
At the individual level, the distribution of the data is skewed.
The skewness coefﬁcient shows the existence of a high negative
asymmetric distribution (g = 1.09).
Modeling the SF-6D
Several models were estimated but only the most appropriate
models are presented here (Tables 4 and 5).
For the mean models (M1 and M2), the majority of coefﬁ-
cients have the expected negative sign. In total, 11 of the 25
coefﬁcients of M1 are signiﬁcant and there are seven inconsis-
tencies. The inclusion of the interaction term (M2) slightly
improved the model because it reduced the number of inconsis-
tencies and increased the number of signiﬁcant coefﬁcients (12).
Compared to a similar model for UK SF-6D in Brazier et al. [1]
M1 has fewer signiﬁcant coefﬁcients (11 vs. 24), more inconsis-
tencies (7 vs. 5) and more positive signiﬁcant coefﬁcients (2 vs. 0)
but better predictive ability according to the proportion of pre-
dictions with an absolute error smaller than 5% (65.45% vs.
52.61%). The performance of M2 compared favorably in terms
of inconsistencies (6 vs. 5) with the similar UK SF-6D model,
which is the model which deﬁnes the UK SF-6D system weights
[1]. However, our model has fewer signiﬁcant coefﬁcients (12 vs.
24) and a larger proportion of predictions with an absolute error
smaller than 5% (63.64% vs. 51.81%).
The OLS model at the individual level with interaction effects
(M4) has 18 coefﬁcients with the expected sign and 18 signiﬁcant
coefﬁcients, but seven inconsistencies. M3 and M4 perform
worse than M1 and M2 in terms of predictive ability, having
smaller MAE and more observations correctly predicted.
However, the comparison of the four models using AIC and BIC
indicates that M3 and M4 present better results. The Reset test
shows evidence of speciﬁcation problems for all models.
However, the results show that all models are overall signiﬁcant.
The predictions of M3 and M4 are unbiased and prediction
errors of M1 and M2 are normally distributed (at the 5% level).
Comparisons between models M3 and M4 with the models
estimated in the UK study are not possible because their results
are not presented in Brazier et al. [1].
The RE models estimated using GLS produce better results
than the OLS regression. M5 and M6 have 23 coefﬁcients with
the expected negative sign and only ﬁve inconsistencies. Further-
more, adding interaction effects to RE (M6) increased the
number of signiﬁcant coefﬁcients from 17 to 20. However,
despite the predictions being unbiased and the high number of
signiﬁcant coefﬁcients, there is evidence of speciﬁcation problems
and of non-normality of the residuals. For both models, the
majority of the overall variance of the error term can be attrib-
uted to the individual effect (rM4 = 0.724; rM5 = 0.725), indicat-
Table 3 Descriptive statistics for the SF-6D health-states valuations
State Va Mean SD Me Min Max State Va Mean SD Me Min Max
111621 10 0.639 0.203 0.639 0.325 0.958 332411 10 0.784 0.134 0.813 0.533 0.938
112554 10 0.737 0.218 0.816 0.278 0.978 334251 11 0.576 0.270 0.618 0.058 0.948
113411 10 0.785 0.099 0.820 0.618 0.878 341123 9 0.725 0.157 0.698 0.483 0.938
115323 10 0.778 0.222 0.868 0.278 0.978 412152 10 0.758 0.156 0.730 0.483 0.993
115653 10 0.608 0.161 0.665 0.325 0.798 414522 10 0.364 0.244 0.336 -0.013 0.675
121212 10 0.771 0.152 0.780 0.483 0.993 421314 9 0.788 0.131 0.808 0.588 0.950
122233 10 0.528 0.198 0.426 0.325 0.798 425131 10 0.575 0.166 0.571 0.325 0.808
122425 10 0.746 0.223 0.835 0.278 0.988 431443 10 0.589 0.209 0.618 0.278 0.808
124125 10 0.625 0.182 0.624 0.363 0.863 432621 10 0.698 0.265 0.793 0.023 0.938
131542 11 0.542 0.266 0.448 0.123 0.963 443215 10 0.798 0.120 0.808 0.663 0.948
132524 10 0.725 0.136 0.683 0.528 0.903 511114 10 0.666 0.235 0.618 0.348 0.958
133132 10 0.539 0.193 0.494 0.325 0.798 512242 10 0.711 0.261 0.818 0.138 0.938
135312 10 0.668 0.201 0.681 0.325 0.958 522321 10 0.629 0.182 0.705 0.313 0.825
142154 11 0.560 0.252 0.448 0.258 0.963 523551 9 0.733 0.132 0.698 0.588 0.913
144341 10 0.762 0.107 0.763 0.618 0.903 531635 10 0.544 0.253 0.521 0.188 0.983
211111 10 0.715 0.124 0.731 0.533 0.863 534113 10 0.487 0.168 0.426 0.275 0.730
211424 10 0.812 0.208 0.865 0.278 0.988 545422 10 0.596 0.290 0.683 0.123 0.878
212145 10 0.693 0.257 0.728 0.253 0.993 611221 10 0.726 0.133 0.763 0.533 0.918
213323 10 0.734 0.196 0.780 0.368 0.993 611434 10 0.774 0.227 0.853 0.278 0.978
221452 10 0.660 0.262 0.785 0.138 0.913 614434 10 0.217 0.314 0.048 -0.088 0.640
224612 9 0.750 0.142 0.753 0.533 0.938 622513 10 0.593 0.306 0.615 0.023 0.978
232111 9 0.831 0.120 0.828 0.663 0.968 625141 10 0.500 0.293 0.581 -0.063 0.843
235224 10 0.620 0.169 0.609 0.368 0.863 631355 10 0.658 0.289 0.689 0.023 0.978
241531 10 0.496 0.231 0.426 0.130 0.798 633122 10 0.451 0.247 0.533 0.020 0.843
312332 10 0.746 0.126 0.763 0.528 0.878 642612 11 0.408 0.322 0.363 -0.148 0.873
315515 10 0.710 0.179 0.725 0.363 0.968 645621 10 0.674 0.269 0.713 0.278 0.978
321122 11 0.631 0.279 0.618 0.123 0.958 645655 * 0.278 0.363 0.300 -0.500 0.950
323644 10 0.677 0.278 0.781 0.080 0.913
*All individuals valued the “pits” state.
Va Number of valuations; SD Standard Deviation; Me Median; Min Minimum: Max Maximum.
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ing a large degree of unobserved individual heterogeneity
[21,22]. Hausman’s test suggests that RE, rather than FE, is the
appropriate speciﬁcation. In addition, B-P LM test implies an RE
rather than an OLS speciﬁcation. Comparing M5 with its UK
SF-6D counterpart reported in Brazier et al. [1], it is possible to
conclude that it presents the same number of signiﬁcant coefﬁ-
cients and similar explanatory power (adjusted RM52 0 194= .
vs. adjusted RBrazier2 0 200= . ). Nevertheless its MAE, is larger
than Brazier’s model (MAEBrazier = 0.073) and presents a
poorer prediction ability (%AE < |0.05|Brazier = 96.50%; %AE <
|0.10|Brazier = 98.49%). Direct comparisons between M6 and a
similar UK SF-6D model estimated by Brazier et al. [1] are not
possible because the authors include another dummy variable
that accounts for all situations where any dimension is at the
least severe level.
ForM7, all coefﬁcients have the expected negative sign and the
vast majority is signiﬁcant, and the model has only ﬁve inconsis-
tencies. The introduction of the interaction term in model M8
slightly improves the results, increasing the number of signiﬁcant
coefﬁcients from 17 to 20 and the variable WORSE is signiﬁcant
and positive. According to QIC, M7 is a better model than M8.
Although bothmodels have speciﬁcation problems, we accept that
the regressions are signiﬁcant overall. The residuals are unbiased,
but are not normally distributed. A comparison between M7 and
a similar UK SF-6D model [1] shows that, in both, all coefﬁcients
are negative, though the number of inconsistencies in M7 is
slightly higher (5 against 4) and the number of signiﬁcant coefﬁ-
cients is lower (17 vs. 26). It also has a poorer prediction ability
(%AE < |0.05|Brazier = 96.53%; %AE < |0.10|Brazier = 98.32%) and
a bigger MAE (MAEBrazier = 0.078). Similarly, M8 performs as
good as the UK counterpart model [1] in terms of its signiﬁcant
coefﬁcients and performs better in terms of the number of incon-
sistencies (one less). However, it has poorer prediction ability
(%AE < |0.05|Brazier = 96.66%; %AE < |0.10|Brazier = 98.55%) and
a bigger MAE (MAEBrazier = 0.076).
M9 has similar results as M7, where the majority of coefﬁ-
cients have the expected negative sign, less inconsistencies and
more signiﬁcant coefﬁcients, but it has a larger QIC. Once more,
it is not possible to compare this model with a similar UK SF-6D
model estimated in Brazier et al. [1] because the authors do not
report their results.
Table 6 shows the parsimonious consistent models con-
structed by aggregating levels of each dimension whenever incon-
sistencies occurred, following other researchers’ approaches [23].
For these models, inconsistent estimates in all dimensions have
been aggregated to attain consistent scales. The parsimonious
consistent model for M7 (M10) is the preferred speciﬁcation and
is paired with the UK SF-6D system weight.
Table 4 OLS models
Aggregated level (mean) Individual level
M1 M2 M3 M4
c 1.000‡ 1.000‡ 1.000‡ 1.000‡
PF2 -0.019 -0.026 0.003 0.000
PF3 0.011 0.009 0.034* 0.034*
PF4 -0.022 -0.027 -0.021 -0.020
PF5 -0.047 -0.046 -0.061* -0.058*
PF6 -0.174† -0.189† -0.190‡ -0.190‡
RL2 -0.022 -0.031 -0.016 -0.021
RL3 -0.079* -0.080* -0.064‡ -0.065‡
RL4 -0.070 -0.085 -0.101‡ -0.109‡
SF2 0.024 0.018 0.003 0.005
SF3 0.004 -0.001 0.008 0.010
SF4 -0.168† -0.177† -0.164‡ -0.165‡
SF5 -0.069* -0.088* -0.090‡ -0.096‡
PN2 0.079* 0.077* 0.070† 0.068†
PN3 0.126† 0.125† 0.133‡ 0.140‡
PN4 0.053 0.053 0.052† 0.055†
PN5 -0.017 -0.023 -0.031 -0.027
PN6 -0.008 -0.021 -0.034 -0.033
MH2 -0.030 -0.041 -0.042† -0.047†
MH3 -0.161‡ -0.166‡ -0.185‡ -0.189‡
MH4 -0.084* -0.090* -0.054† -0.062†
MH5 -0.065 -0.085* -0.095‡ -0.104‡
VT2 -0.091* -0.087* -0.078‡ -0.076‡
VT3 -0.082* -0.075* -0.074‡ -0.074‡
VT4 -0.046 -0.046 -0.005 -0.010
VT5 -0.014 -0.029 -0.059‡ -0.067‡
WORSE — 0.039 — 0.025
n 55 55 630 630
Inconsistencies 7 6 7 7
MAE 0.061 0.059 0.197 0.196
%AE < |0.05| 65.45 63.64 15.87 15.87
%AE < |0.10| 78.18 78.18 29.84 29.68
t(mean = 0) (1) (1) -0.597 -0.575
RESET 5.36† 4.84† 5.24† 2.77*
F 287.14‡ 273.81‡ 1369.53‡ 1322.29‡
JB 2.954 2.926 36.39‡ 36.17‡
AIC -146.573 -145.960 -1223.112 -1223.776
BIC -94.383 -91.762 -1107.524 -1103.741
(1) Mean error is zero by deﬁnition. *P < 0.10. †P < 0.01. ‡P < 0.001.
PF, Physical functioning; RL,Role limitations; SF, Social functioning; PN, Pain;MH,Mental health;
VT,Vitality; M1, main effects; M2, interaction effects; M3, main effects; M4, interaction effects.
Table 5 RE and GEE models (individual level: n = 630)
RE GEE
Log-Log
transformation
(GEE)
M5 M6 M7 M8 M9
c 0.827‡ 0.817‡ 1.000‡ 1.000‡ 1.000‡
PF2 -0.041* -0.040* -0.050† -0.050* -0.065*
PF3 -0.025 -0.024 -0.032 -0.031 -0.041
PF4 -0.040* -0.036* -0.049* -0.045* -0.066*
PF5 -0.045* -0.042* -0.055* -0.052* -0.069*
PF6 -0.177‡ -0.179‡ -0.214‡ -0.220‡ -0.320‡
RL2 -0.026 -0.028* -0.031 -0.034* -0.065*
RL3 -0.003 -0.003 -0.003 -0.003 -0.014
RL4 -0.046* -0.056† -0.054* -0.067† -0.112†
SF2 -0.031* -0.033* -0.038* -0.042* -0.055*
SF3 -0.012 -0.015 -0.014 -0.019 -0.032
SF4 -0.034 -0.052* -0.039 -0.060* -0.095*
SF5 -0.057† -0.066† -0.069† -0.080† -0.114†
PN2 0.006 0.007 0.006 0.008 0.011
PN3 0.001 0.007 -0.001 0.006 0.127
PN4 -0.049* -0.047* -0.061* -0.060* -0.074*
PN5 -0.044* -0.050* -0.054* -0.060* -0.096†
PN6 -0.073‡ -0.073‡ -0.090‡ -0.090‡ -0.127‡
MH2 -0.048† -0.054† -0.059† -0.066† -0.095†
MH3 -0.011 -0.025 -0.009 -0.026 -0.045
MH4 -0.057† -0.059† -0.070† -0.073† -0.101†
MH5 -0.085‡ -0.092‡ -0.103‡ -0.112‡ -0.180‡
VT2 -0.043‡ -0.040* -0.051† -0.048† -0.070*
VT3 -0.031 -0.026 -0.036 -0.031 -0.059*
VT4 -0.037† -0.039† -0.046† -0.048† -0.070†
VT5 -0.080‡ -0.082‡ -0.097‡ -0.101‡ -0.136‡
WORSE — 0.033* — 0.038* 0.054*
Adjusted R2 0.194 0.208 — — —
Inconsistencies 5 5 5 5 3
MAE 0.209 0.207 0.209 0.207 0.225
%AE < |0.05| 14.44 14.13 14.29 14.29 13.02
%AE < |0.10| 28.25 28.57 28.41 28.25 27.94
t(mean = 0) 0.000 0.000 0.000 0.000 5.419‡
RESET 14.39‡ 7.44† 14.65‡ 14.46‡ 15.47‡
W(c2) 703.05‡ 711.29‡ 762.57‡ 769.61‡ 786.38‡
JB 25.72‡ 25.37‡ 25.63‡ 25.28‡ 0.19
QIC — — 68.069 68.231 153.387
*P < 0.10. †P < 0.01. ‡P < 0.001.
PF, Physical functioning; RL,Role limitations; SF, Social functioning; PN, Pain;MH,Mental health;
VT,Vitality.
M5, main effects; M6, interaction effects; M7, main effects; M8, interaction effects; M9,
interaction effects.
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Figure 1 compares the predicted health-state values of M10
with observed values. It shows that although the tendency to
under predict mild health states has been reduced, there is still a
problem of under prediction for severe health states. It is clear
from the ﬁgure that M10 adequately predicts the observed
health-state values.
Discussion
The SF-6D is one of the most widely used HRQoL measurement
instruments. Since it was developed in 2002, several authors have
studied its properties, its usefulness, as well as its limitations.
Many comparisons of SF-6D with other HRQoL measurement
instruments have also been published. There have also been some
articles reporting the estimation of system weights for the SF-6D
for other countries [24,25].
This study reports the results of the survey conducted to
estimate the Portuguese system weights for the SF-6D. The
results demonstrate that it is possible to estimate preference
weights for HRQOL measurement for use in Portugal. The best
econometric models adequately predict the health-state values
for the general population. Actually, the performance of the RE
models with the constant restricted to unity performed better
than the FE models. Hence, the recommended PT SF-6D system
weights are based on a GEE model with main effects with no
inconsistencies (M10). The restriction of the intercept to unity is
sustained by the need to generate models for use in cost-utility
analyses. Parsimonious consistent models aggregating the levels
where there are inconsistent estimates are chosen due to concerns
regarding some inconsistent estimates for two levels of the six
dimensions. It is worth further research on the under-prediction
of the value of the most severe health states observed in some
cases. The results were consistent with the valuation studies
conducted in UK [1,11]. Socio-demographic data were not
included in the models following other valuation surveys
reported in the literature [1,14,23,26–28].
Some authors [29] recommend multiplicative models to esti-
mate preference functions for multiattribute health-state classiﬁ-
cation systems. When compared to additive models, they have
the ability to capture interactions between the attributes to a
limited degree. The functional form used in the PT SF-6D is a
linear additive one, due to the difﬁculties of estimating and
interpreting different functional forms given the nature of the
independent variables. The data are explained in terms of a
model with one additional term to account for the much greater
disutility associated with extreme problems, similar to the model
Table 6 Parsimonious consistent models (individual level: n = 630)
M10-Main
effects
M11-Interaction
effects
c 1.000 1.000
PF23 -0.029 -0.028
PF4 -0.047 -0.042
PF5 -0.050 -0.046
PF6 -0.207 -0.213
RL23 -0.012 -0.013
RL4 -0.061 -0.073
SF23 -0.025 -0.028
SF4 -0.051 -0.071
SF5 -0.075 -0.086
PN23 0.000 0.000
PN45 -0.049 -0.052
PN6 -0.087 -0.089
MH23 -0.038 -0.047
MH4 -0.066 -0.070
MH5 -0.100 -0.111
VT23 -0.040 -0.036
VT4 -0.041 -0.043
VT5 -0.092 -0.096
WORSE — 0.041
MAE 0.207 0.205
%AE < |0.05| 13.81 14.60
%AE < |0.10| 29.37 28.89
t(mean = 0) 0.006 -0.007
RESET 19.2* 15.3*
W(c2) 741.23* 751.16*
JB 26.42* 26.07*
QIC 62.865 0.000
All the coefﬁcients are signiﬁcant at the 0.10 level. *P < 0.001.
PF-Physical functioning; RL-Role limitations; SF-Social functioning; PN–Pain; MH-Mental
health;VT–Vitality.
M10-parsimonious consistent model for M7; M11-parsimonious consistent model for M8.
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Figure 1 Actual and predicted health-state valuations for M10.
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used for the valuation of the EQ-5D [26]. However, due to the
positive sign of the additional term, the preferred speciﬁcation is
a main effects model.
There may be a concern with the small sample size used in the
study. The valuation data set is small in terms of both the number
of health-state values and the number of respondents, when
considering other valuation studies such as the EQ-5D valuation
survey [26] or the SF-6D valuation survey undertaken by Brazier
et al. [1]. In fact, the results presented here are from 140 respon-
dents, valuing 0.31% of the possible health states generated by
the SF-6D. The EQ-5D model was estimated from a sample of
2,997 respondents that valued 43 of the possible health states
(17.3%) and the SF-6D was estimated from a sample of 611
individuals that valued 1.4% of the possible health states [14]. A
larger sample and an increase in the number of health states
valued would probably contribute to a better predictive model.
However, it is worth noticing that a random sample was used,
therefore allowing for inference over the Portuguese population.
In the future, we intend to use conﬁrmatory analysis and
structural equation models to determine the measurement prop-
erties of the latent factors underlying the HRQoL of the Portu-
guese general population and to estimate the magnitude and
direction of the interdependent effects among those factors. We
also intend to model health-state preference data using rank data
and to compare both the rank and the SG approaches.
Conclusion
The valuation and estimation of a multiattribute preference-
based index is a complex task. In this study, we estimated the
Portuguese system weight for the SF-6D that can be used in
future studies for determining the HRQoL of the Portuguese
population.
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